Florence Dartiguenave

ILC2-modulated T cell–to-MDSC balance is associated with bladder cancer recurrence

Mathieu F. Chevalier, Sara Trabanelli, Julien Racle et al. · Journal of Clinical Investigation · 2017 · 220 citations · Full text

Medicine, Immunology, Oncology +17

Double Positive CD4+CD8+ T Cells Are Enriched in Urological Cancers and Favor T Helper-2 Polarization

Perrine Bohner, Mathieu F. Chevalier, Valérie Cesson et al. · Frontiers in Immunology · 2019 · 92 citations · Full text

Life Sciences, Immunology, Oncology +17

Intravesical Bacillus Calmette Guerin Combined with a Cancer Vaccine Increases Local T-Cell Responses in Non-muscle–Invasive Bladder Cancer Patients

Laurent Derré, Valérie Cesson, Ilaria Lucca et al. · Clinical Cancer Research · 2016 · 46 citations · Full text

Medicine, Immunology, Oncology +17

Quantitative and qualitative impairments in dendritic cell subsets of patients with ovarian or prostate cancer

Béatris Mastelic-Gavillet, Apostolos Sarivalasis, Leyder Elena Lozano et al. · European Journal of Cancer · 2020 · 46 citations · Full text

Life Sciences, Immunology, Oncology +15

Vδ2 T cells are associated with favorable clinical outcomes in patients with bladder cancer and their tumor reactivity can be boosted by BCG and zoledronate treatments

Sylvain Nguyen, Mathieu F. Chevalier, Sulayman Benmerzoug et al. · Journal for ImmunoTherapy of Cancer · 2022 · 29 citations · Full text

Medicine, Immunology, Oncology +17